Pharmacological Profile of Prednisolone
Prednisolone is characterized by high penetrance. It easily crosses various blood-tissue barriers, effectively penetrating the skin and mucous membranes.
When evaluating the activity spectrum of prednisolone compared to natural hydrocortisone, there is a clear shift in profile. Glucocorticoid activity is significantly stronger in prednisolone, providing a potent effect. Conversely, mineralocorticoid activity is reduced: the drug has a much lower tendency to cause sodium and water retention in the body.
Systemic effects of prednisolone manifest as a pronounced dose-dependent influence on metabolism. The direction of these metabolic changes is predominantly catabolic. The primary target tissues susceptible to this effect include:
- lymphoid tissue;
- adipose tissue;
- connective tissue;
- skeletal muscle;
- skin.
Advantages of Methylprednisolone
The key pharmacokinetic advantage of methylprednisolone lies in its ability to undergo selective distribution. Unlike prednisolone, it is targetedly accumulated precisely within inflamed tissues, creating high concentrations there, whereas its levels in healthy tissues remain minimal. This property significantly increases the therapeutic efficacy of the drug directly at the pathological focus.
Additionally, methylprednisolone has a more favorable safety profile compared to its predecessor. Treatment is associated with:
- a lower risk of skin and muscle atrophy;
- a reduced negative impact on bone tissue, clinically manifested as a lower risk of developing osteoporosis.
It is precisely due to this combination of high targeted efficacy and an improved safety profile that methylprednisolone is recognized as the drug of choice for long-term therapy.
Pulse Therapy: Protocol and Side Effects
For the treatment of severe, rapidly progressing inflammatory diseases, a specialized technique is used: pulse therapy. The drug of choice for this protocol is exclusively methylprednisolone.
Administration Protocol:
- A single intravenous administration is performed at ultra-high doses (the minimum dose is 1 gram).
- The infusion is carried out at a high rate—the entire volume of the drug must enter the bloodstream within 30–60 minutes.
- The duration of such a course is strictly limited to no more than 3 days.
Despite high clinical efficacy, pulse therapy carries the risk of specific adverse effects. Vascular side effects frequently include facial flushing and arterial hypertension. Neurological and sensory reactions may include altered taste, as well as severe muscle and joint pain. In the metabolic profile, the most significant complication is hyperglycemia.